NIH-funded research NIH-funded research

Improving diagnosis and outcomes for primary progressive aphasia

Official title: Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia

Funded at Massachusetts General Hospital · NIH-10634041 · Data updated 2026-11-12

This study is looking at ways to better understand and diagnose primary progressive aphasia (PPA), a condition that affects how people communicate, by using advanced brain imaging techniques, so that doctors can provide better care and support for those living with PPA.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 17, 2023
Project endMarch 31, 2026
Funding year2023
Award (this year)$2,515,977
NIH project number1RF1NS131395-01
Project IDNIH-10634041 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with primary progressive aphasia or those exhibiting early symptoms of this condition.

Less likely to help

Patients with other forms of dementia or cognitive disorders unrelated to primary progressive aphasia may not benefit from this research.

What this research studies

This research focuses on primary progressive aphasia (PPA), a neurodegenerative condition that primarily affects language abilities while sparing other cognitive functions in its early stages. The team aims to develop advanced imaging techniques, including tau and amyloid imaging, to differentiate between the various subtypes of PPA and their underlying causes. By utilizing functional connectivity MRI and other imaging methods, the research seeks to provide more accurate diagnoses and better prognostic tools for monitoring disease progression and treatment effects. This could lead to improved clinical practices for healthcare providers treating patients with PPA.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of primary progressive aphasia, ultimately improving patient management and treatment outcomes.

How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for diagnosing neurodegenerative diseases, suggesting that this approach could be effective for PPA as well.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Dickerson, Bradford C — Massachusetts General Hospital
  • Study coordinator: Dickerson, Bradford C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.